Literature DB >> 18425779

Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience.

Antonio Augusto Ornellas1, Eduardo Wei Kinchin, Bernardo Lindenberg Braga Nóbrega, Aristóteles Wisnescky, Nelson Koifman, Raul Quirino.   

Abstract

BACKGROUND AND OBJECTIVES: We reviewed our long-term experience with surgical treatment of patients with penile carcinoma.
METHODS: From 1960 to 2006, 688 patients with penile carcinoma underwent surgical treatment at our Institute. Several forms of surgical treatment were compared and follow-up data analyzed.
RESULTS: Stage stratification demonstrated a better survival rate for patients with stages T1N0 and T1N1,T2N0-1. Patients with well differentiated carcinoma had a higher survival rate than those with moderately and poorly differentiated carcinoma (P < 0.0001 and P = 0.006). Risk stratification showed a better survival rate for patients in the low-risk group (T1G1,T1G2) (P = 0.013 and P < 0.00001). Patients in the intermediate group (T2G1,T2G2,T3G1,T3G2) presented a higher survival rate than patients in the high-risk group (T1-3G3,T4G1-3) (P < 0.00001). Patients who underwent immediate lymphadenectomy had a better survival rate than those who underwent delayed lymphadenectomy (P = 0.002).
CONCLUSIONS: Stage and tumor grade affected the prognosis of the disease. The presence and the extent of metastasis to the inguinal region were the most important prognostic factors for survival in our patients. Immediate lymphadenectomy is indicated in all patients. Since recurrences were noted within 8, 10, and 25 years after primary treatment, a frequent and lasting follow-up is essential for all patients. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18425779     DOI: 10.1002/jso.20980

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  37 in total

1.  [Organ-preserving therapy for penile carcinoma].

Authors:  O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

2.  Validation of predictors for lymph node status in penile cancer: Results from a population-based cohort.

Authors:  X Melody Qu; D Robert Siemens; Alexander V Louie; Darwin Yip; Aamer Mahmud
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

Review 3.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

4.  Hidden penile squamous cell carcinoma: A case report.

Authors:  Sam Neufeld; Tadeusz Kroczak; Darrel Drachenberg
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 5.  Penile preserving and reconstructive surgery in the management of penile cancer.

Authors:  Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2016-03-22       Impact factor: 14.432

Review 6.  Sentinel node biopsy and lymphatic mapping in penile and prostate cancer.

Authors:  H G van der Poel; P Meershoek; N Grivas; G KleinJan; F W B van Leeuwen; S Horenblas
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

Review 7.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

8.  Inguinal Lymph Nodes in Carcinoma Penis-Observation or Surgery?

Authors:  Syed Althaf; Rajkumar P Narayanakar; Dinesh M Gangaiah; Kapil Dev; Vishnu P Kurpad; Jaiprakash Gurawalia
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 9.  [Conventional grading vs. molecular grading : Decision aids for clinical routine].

Authors:  C Kakies; D Louise Dräger; P Spiess; O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2021-06-28       Impact factor: 0.639

10.  DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.

Authors:  Oliver J Kayes; Marco Loddo; Nimish Patel; Pranav Patel; Suks Minhas; Gareth Ambler; Alex Freeman; Alex Wollenschlaeger; David J Ralph; Kai Stoeber; Gareth H Williams
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.